Hot Deals:
a v thomas 15,555.00 (3.70 %) adtech 29.10 (0.34 %) agarwal bolts 1,200.00 (-0.83 %) amol minechem 620.00 (1.64 %) anand i-power 20.00 anglo french 350.00 (-5.41 %) apl metals 42.01 (0.02 %) arkfin investments 50.00 arohan 115.00 (-2.54 %) assam carbon 195.00 (-4.88 %) atlas copco 10,000.00 (1.01 %) auckland international 129.00 (-0.77 %) axles 185.00 (5.71 %) balmer lawrie 199.00 (1.02 %) bharat hotels 144.00 (-0.69 %) bima mandi 700.00 bira 650.00 (3.83 %) boat 715.00 (-1.38 %) c & s electric 505.00 (1.00 %) cable corporation 15.00 capgemini 10,700.00 (1.86 %) care health 154.00 (1.99 %) carrier aircon 276.00 (0.36 %) cial 163.00 (1.24 %) csfbl 365.00 (-3.44 %) csk 160.00 (-1.84 %) dalmia refract 130.00 (4.00 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 48.00 (2.13 %) eaton fluid 440.00 (-2.22 %) electronica plastic 4,100.00 (-0.24 %) elgi ultra 400.00 elofic 1,970.00 (3.68 %) esl steel 32.00 (-3.03 %) fincare business 43.00 fincare sfbl 191.00 (0.53 %) finopaytech 119.00 (-0.83 %) flipkart india 231,001.00 (0.00 %) frick india 3,800.00 (2.70 %) gkn drive 1,090.00 (-0.91 %) go digit general insurance ltd 354.00 (1.14 %) godavari bio 71.00 (1.43 %) hdb financial 650.00 (0.78 %) hdfc ergo 370.00 (1.70 %) hdfc securities 10,111.00 (2.13 %) hella india 550.00 (10.00 %) hero fincorp 1,050.00 (1.94 %) hexaware 530.00 (1.92 %) hicks 1,700.00 (-0.58 %) hira ferro 120.00 (-0.83 %) honeywell electrical 3,333.00 (-1.97 %) icex 0.10 (-0.10 %) ikf finance 214.00 (4.90 %) incred financial 100.00 india carbon 945.00 (-0.53 %) india exposition 144.00 (-1.37 %) indian potash 1,390.00 (-0.71 %) indofil 650.00 (-2.99 %) infinite computer 405.00 (1.25 %) inkel 12.00 (-1.64 %) ixigo 87.00 (-1.14 %) jana sfbl 75.00 kel 550.00 (3.77 %) kial 104.00 (-0.95 %) klm axiva 17.50 (-1.13 %) kurlon limited 310.00 (1.31 %) lava 96.00 (-1.03 %) manipal housing 72.50 (0.69 %) manjushree tech 930.00 (3.33 %) martin & harris 1,080.00 (-1.82 %) merino 2,530.00 (-0.78 %) minosha 282.00 (0.71 %) mkcl 345.00 (1.47 %) mobikwik 360.00 (2.86 %) mohan meakin 1,400.00 (-2.10 %) mohfl 10.90 (-8.40 %) msei 0.91 (-1.09 %) msil 55.00 (1.85 %) nayara energy 195.00 (2.63 %) nayara energy ncd 255.00 (-1.92 %) ncdex 275.00 ncl buildtek 229.00 (0.88 %) ncl holdings 65.00 (3.17 %) nse 3,200.00 (3.23 %) orbis financial 82.00 (2.50 %) oswal minerals 63.00 (-3.08 %) otis 3,500.00 (-2.78 %) oyo 64.00 (-1.54 %) panasonic appliances 295.00 (0.68 %) panasonic avc 29.10 (0.34 %) paymate india 505.00 (-4.72 %) pharmeasy 20.80 (-0.95 %) philips 950.00 (-3.06 %) philips domestic 580.00 (1.75 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 320.00 (3.23 %) rasoi 31,500.00 (0.32 %) reliance gic 330.00 (-2.94 %) resins plastics 420.00 (2.44 %) ring plus 404.00 (-0.25 %) rrl 2,500.00 (-1.96 %) sab miller 305.00 (0.66 %) sbi amc 900.00 (-1.10 %) scottish assam 443.00 (-1.56 %) shriram life 261.00 (0.38 %) sigachi lab 39.00 (-2.74 %) signify 1,400.00 (7.69 %) simpson & company 1,000,000.00 smile micro 52.00 (-1.89 %) sportskeeda 3,303.00 sterlite power 475.00 (1.06 %) studds 770.00 (-2.53 %) svsml 430.00 (-2.27 %) swiggy 361.00 (0.28 %) t stanes 750.00 (2.74 %) tata capital 178.00 (1.71 %) tata tech 827.00 (-0.36 %) teesta agro 81.00 (1.25 %) trl krosaki 1,255.00 (0.40 %) utkarsh core 135.00 (-1.46 %) vikram solar 350.00 (2.94 %) waree energie 600.00
×

Martin & Harris Share Price

Company Name
Martin And Harris Laboratories Limited
Last Traded Price (LTP)
1,080.00
% Change
-1.82 %
Scrip Name
Martin & Harris
ISIN No.
INE03VV01015
PAN No.
AABCM0832A
Face Value
10
No. of Outstanding Shares
3,996,040
Market Capitalization
431.57 Crore
Book value
1115.133
P/BV
0.9685
EPS
442.598
PE ratio
2.44
Available on
nsdl
ROFR Require
No

Martin and Harris Laboratories Limited Unlisted Share – Company Overview

MARTIN AND HARRIS LABORATORIES LIMITED was first established in 1996 and is based in Gurgaon, Haryana. The company is a part of Apeejay Group, which is India’s oldest and largest Conglomerates. Apeejay Group is a leading Industrial & Investment house with businesses in Automotive, Chemicals & Plastics, Distribution, Logistics & Retail, Pharmaceuticals & life sciences, real estate, and international trading and a nascent presence in IT, merchant banking & financial services and publishing.

Martin and Harris Laboratories Limited is primarily engaged in the business of manufacturing pharmaceuticals, medicinal chemicals & botanical products. The company intensively focuses on drugs used for Hyper Tension, High blood pressure, and heart attack. Apart from its primary business, the company also undertakes fund management through investment in different avenues like mutual funds, equity, etc.

Martin and Harris Laboratories Limited has two units located at Roorkee, Uttarakhand, and Una in Himachal Pradesh. The company is continuously striving to expand its manufacturing facilities and meet global standards.

The company was awarded ‘Best Pharma Excellence awards’ in 2018 by ASSOCHAM India.

Martin And Harris Laboratories Limited Incorporation Details

CIN of Martin and Harris Laboratories

U24239HR1993PLC033630

Registration Date of Martin and Harris Laboratories

22 July 1993

Category/Sub-category of Martin and Harris Laboratories

Company Limited by Shares

Martin and Harris Laboratories Registered office address 

NH-8, Delhi Jaipur Highway,

Village, Pachgaon (Fazalwas),

District Gurgaon, Haryana

Martin and Harris Laboratories Registrar and Transfer Agent address and contact details

NA

Martin And Harris Laboratories Limited Principal Business Activities

Name and Description of main products/services

NIC Code of the product/service

% to total turnover of the Company

Manufacture of Pharmaceutical, Medicinal Chemical & Botanical Products

210

52.03%

Fund management activities

663

47.97%

Martin And Harris Laboratories Limited Board of Directors

MR. S. L. LAAD

MR. G. K. NIGAM

MR. AJAY GROVER

MR. H. S. THAKUR

Martin And Harris Laboratories Particular of Subsidiary Companies

Name of the Company

% of shares held

Delite Infrastructure Private limited

100.00%

Martin And Harris Laboratories Limited Shareholding Pattern (As on 31-03-2020)

S. No.

Shareholders’ Name

Number of shares

% of total Shares of the company

1

Promoters Shareholding

140

0.004%

2

Public Shareholding

39,95,900

99.996%

 

Total

39,96,040

100.00%

Industry Outlook

 Indian Pharmaceutical market ranks as 3rd largest in the world in terms of volume and 14th largest in terms of value. Healthcare has become one of the largest sectors of the Indian economy, in terms of both employment and revenue. India is known as the Pharmacy of the world and is the largest provider of generic drugs at a global level. The pharmaceutical industry of India supplies over 50% of the global demand for various vaccines, 40% of generic demands in the USA, and 25% of all the medicines in the United Kingdom. Excellent Research & Development, low cost of labor, availability of management and technical personnel, and local equipment’s availability has helped India to manufacture pharma products at a very low cost.

The Indian healthcare market may see a 3 fold jump in terms of value to reach US$ 372 billion by FY 2022. The growth can be attributed to rising income, greater health awareness, increased precedence of lifestyle disease, and Indian prominence in making medicinal products for the treatment of COVID 19. India aims to achieve vaccination for COVID-19 of 30 Crore people in the next few months.

Export of Pharmaceuticals products from India stood at US$ 16.8 billion in FY 2020 and US$ 2.07 billion in the month of October 2020. In the first 3 quarters of FY 2021, India exported pharmaceuticals worth US$ 15.86 billion. India supplied around 45 tons and 400 million tablets of hydroxychloroquine to around 114 countries globally to treat the covid patients in the initial stage of the covid-19 pandemic. Exports in FY 2021 of Indian pharma products are expected to cross US$ 24 billion, increasing by over 16% when compared to FY 2020.

After the onset of COVID 19, the Indian pharmaceutical sector became the busiest sector in the Indian economy. The pandemic proved to be a boon in disguise for the Indian pharmaceutical sector.

Annual Report

Martin And Harris Laboratories Annual Report 2019-20

Download

Recent News

Wealth Wisdom - WWIPL
Support Megha Support Neha